India's Pharmaceutical Exports

Country Profile

North Korea

North Korea is a developing market for Indian pharmaceuticals — $4.08M in FY 2025–26. Vaccines accounts for 95% of shipments, with vaccines contributing $3.88M.

🇰🇵 $4.08M · 1.0× growth since FY2015
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$4.08M
Exports FY2025–26 DGCIS
1.0×
Growth FY2015→2026
95%
Vaccines Share
3
Product Categories Supplied
7
Years of Trade Data
North Korea is a developing market for Indian pharmaceuticals — $4.08M in FY 2025–26. Vaccines accounts for 95% of shipments, with vaccines contributing $3.88M.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Vaccines $3.88M (95.1%) Medicines $177K (4.3%) Medicine Ingredients $24K (0.6%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to North Korea in the RBI overseas direct investment dataset (2011–2026).